Somnath Mukherjee

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. pmc Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
    Somnath Mukherjee
    Gray Institute for Radiation Oncology and Biology, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK Electronic address
    Lancet Oncol 14:317-26. 2013

Collaborators

Detail Information

Publications1

  1. pmc Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
    Somnath Mukherjee
    Gray Institute for Radiation Oncology and Biology, University of Oxford, NIHR Oxford Biomedical Research Centre, Oxford, UK Electronic address
    Lancet Oncol 14:317-26. 2013
    ..We aimed to assess the activity, safety, and feasibility of both gemcitabine-based and capecitabine-based chemoradiotherapy after induction chemotherapy for patients with locally advanced pancreatic cancer...